Haemonetics | HAE - Operating Profit


Haemonetics reported $57.46M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 222M 253M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
ICU Medical USD 60.43M 30.05M Jun/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Neogen USD -1.8M 4.9M Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Quidel USD -15.3M 16.5M Jun/2026
ResMed USD 454.34M 51.33M Jun/2026
STAAR Surgical USD 10.1M 7.3M Jun/2026
Steris USD 285.8M 32.9M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
US Physical Therapy USD 16.39M 3.97M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026